Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()

BACKGROUND/AIMS: Angiotensin-converting enzyme 2 (ACE2), its product, angiotensin-(1–7) and its receptor, Mas, may moderate the adverse effects of angiotensin II in liver disease. We examined the expression of these novel components of the renin angiotensin system (RAS) and the production and vasoac...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Hepatol
Auteurs principaux: Herath, Chandana B., Warner, Fiona J., Lubel, John S., Dean, Rachael G., Jia, Zhiyuan, Lew, Rebecca A., Smith, A. Ian, Burrell, Louise M., Angus, Peter W.
Format: Artigo
Langue:Inglês
Publié: European Association for the Study of the Liver. Published by Elsevier Ireland Ltd. 2007
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7114685/
https://ncbi.nlm.nih.gov/pubmed/17532087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2007.03.008
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires